The U.S. next generation sequencing market size was valued at USD 2.85 billion in 2025 and is predicted to hit around USD ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Healthcare Asia Magazine on MSN
Next-generation sequencing services market to reach $8.77b by 2030
The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...
(RTTNews) - Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback